Surgical Innovations Group Plc (SUN) Earns Buy Rating from N+1 Singer

Surgical Innovations Group Plc (LON:SUN)‘s stock had its “buy” rating reaffirmed by stock analysts at N+1 Singer in a note issued to investors on Wednesday.

Shares of Surgical Innovations Group Plc (LON SUN) opened at 4.575 on Wednesday. The stock has a 50 day moving average of GBX 4.10 and a 200-day moving average of GBX 3.78. Surgical Innovations Group Plc has a 12 month low of GBX 2.25 and a 12 month high of GBX 4.63. The firm’s market capitalization is GBX 24.40 million.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.thestockobserver.com/2017/09/13/surgical-innovations-group-plc-sun-earns-buy-rating-from-n1-singer.html.

In other news, insider Paul Hardy bought 815,721 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The stock was purchased at an average price of GBX 3 ($0.04) per share, with a total value of £24,471.63 ($31,604.84).

Surgical Innovations Group Plc Company Profile

Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships.

Receive News & Ratings for Surgical Innovations Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Innovations Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply